Insider · CIK 0001685986
Shamim Ruff
Files at RETA (REATA PHARMACEUTICALS INC). First filing Mar 13, 2023, latest Mar 13, 2023.
In brief
Shamim Ruff files SEC Form 4 as director at RETA (REATA PHARMACEUTICALS INC). Since Mar 13, 2023, Shamim Ruff has reported 0 open-market buys worth $0 and 1 open-market sell worth $481k, the latest filed on Mar 13, 2023.
A track record needs three past buys with six months of prices behind them; Shamim Ruff has 0, so none is measured yet.
The newest scored trade: sold $481k of RETA on Mar 10, 2023, filed Mar 13, 2023, scored 53 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | REATA PHARMACEUTICALS INC | $481k 5,740 shares | -52% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | RETA REATA PHARMACEUTICALS INC | MOption exercise Class A common stock | +199 | $27.32 | $5,437 | 5,422 | Mar 13, 2023 |
| Mar 10, 2023 | RETA REATA PHARMACEUTICALS INC | MOption exercise Class A common stock | +1,326 | $34.76 | $46k | 6,748 | Mar 13, 2023 |
| Mar 10, 2023 | RETA REATA PHARMACEUTICALS INC | MOption exercise Class A common stock | +4,215 | $34.76 | $147k | 10,963 | Mar 13, 2023 |
| Mar 10, 2023 | RETA REATA PHARMACEUTICALS INC | SOpen-market sale Class A common stock | -5,740 | $83.73 | $481k | 5,223 | Mar 13, 2023 |
| Mar 10, 2023 | RETA REATA PHARMACEUTICALS INC | MOption exercise Stock Option (right to buy)derivative | -199 | $0.00 | $0 | 0 | Mar 13, 2023 |
| Mar 10, 2023 | RETA REATA PHARMACEUTICALS INC | MOption exercise Stock Option (right-to-buy)derivative | -1,326 | $0.00 | $0 | 443 | Mar 13, 2023 |
| Mar 10, 2023 | RETA REATA PHARMACEUTICALS INC | MOption exercise Stock Option (right-to-buy)derivative | -4,215 | $0.00 | $0 | 1,405 | Mar 13, 2023 |
Questions about Shamim Ruff
Answered from the filings on this page, as of the latest one.
Is Shamim Ruff buying or selling?
Not in the last 12 months. Shamim Ruff's latest open-market trade on SEC Form 4 was sold $481k of RETA on Mar 10, 2023.
How did Shamim Ruff's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shamim Ruff has 0.
Where does Shamim Ruff file Form 4?
Shamim Ruff has filed Form 4 at RETA (REATA PHARMACEUTICALS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.